Case Report
Copyright ©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 7076-7084
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7076
Table 1 Laboratory tests of patients

No symptoms
Start symptoms
Start treatment
After treatment
Laboratory parametersFebruary 22March 10March 16March 24
AST, UI/L24223226
ALT, UI/L19281624
Total bilirubin (µmol/L)6.53.588
Albumin (g/L)33353331
Creatinine (µmol/L)118.6119135134.5
Hemoglobin (g/L)12.112.512.511.7
Platelet159000122000136000296000
Lymphocytes10201050390996
PT (%)100862788
INR11.051.51.1
Tacrolimus (ng/mL)3.53.53.23.8
CRP (mg/L) 3.0512.4112.286.6
Table 2 Clinical and biological characteristics of patients with coronavirus disease 2019 pneumonia after liver transplanta
Ref.
Study type
Patients (n)
Age (yr)
Time from transplantation
Clinical manifestations
Immunosuppression treatment
Immunosuppression, modification
Metabolic comorbidities
Death
Fernández-Ruiz et al[8]Case series6637.9 yrFever, shortness of breath, coughEVEYesHypertension, diabetesNo
725.5 yrFever, shortness of breath, coughMMF, EVEYesHypertension, diabetes, obesityYes
7915.3 yrShortness of breath, cough, malaise, diarrheaPrednisone AZA, EVEYesDiabetes, chronic renal failureYes
7316.4 yrFever, shortness of breath, cough, malaiseMMFYesDiabetesYes
7626.5 yrFever, thoracic, painTacrolimusNoHypertensionNo
466.4 yrDiarrheaTacrolimusNoNo
Bhoori et al[7]Correspondence6> 65> 10 yrYesYes
> 65> 10 yrYesDiabetes, overweight, hyperlipidemiaYes
> 65> 10 yrYesDiabetes, overweight, hyperlipidemiaYes
< 2 yrCalcineurin inhibitorsYesDiabetes, overweight, hyperlipidemiaNo
< 2 yrCalcineurin inhibitorsYesNo
< 2 yrCalcineurin inhibitorsYesNo
Huang et al[9]Case report1593 yrFever, cough, chills, fatigue, icterus and diarrheaMMF et tacrolimusYes
Qin et al[6]Case report13753 dPersistent feverTacrolimus and glucocorticoidsNo